Nefrotoxicidade da Cisplatina
DOI:
https://doi.org/10.32635/2176-9745.RBC.1986v32n3.3265Keywords:
Cisplatinum, Nephrotoxicity, Chemotherapy, Antineoplasic TherapyAbstract
Two hundred and ninety two patients were treated wíth 1.106 courses of Cisplatinum (DDP) with nephrotoxicity of 9.7% (7.9% mild, 1.6% moderate and 0,2% severe). Two hundred and three patientes (757 courses) were treated in an outpatient regímen and the DDP was given without previous hydration and in a three-hour infusion schedule. The renal toxicity observed in this group was 10. 1% (8.4% mild, 1.4% moderate and 0.2% severe). All patients were studied according to the presence of previous renal function abnormalities, methods of drug administration, primary tumor sites, dosage per course, schedule of DDP administration and cumulatives doses. The presence of previous renal function abnormalities was found to be the most important factor in developing nephrotoxicity with the use of DDP (P <a 0001). No relationship was found between nephrotoxicity and the method of DDP administration, primary tumor sites, dosis given per courses, schedule of administration and cumulatíve doses. The administration of DDP on an outpatient regimen with no previous hydration is safe and with acceptable renal toxicíty.
Downloads
References
Rosenberg B: Fundamental studies with cisplatin. Cancer 1985, 55: 2303-2316. DOI: https://doi.org/10.1002/1097-0142(19850515)55:10<2303::AID-CNCR2820551002>3.0.CO;2-L
Rosenberg B: Cisplatin:Its history and possible mechanisms of action, in Prestayko AW. Crooke ST, Carter SK (eds) - Cisplatin: current and new developments. New York, Academic Press, 1980, 9-20. DOI: https://doi.org/10.1016/B978-0-12-565050-2.50006-1
Cvitkovic E. Spaulding J, Bethune V, Martin J, Withmore WF. lmprovement of cis-dichlorodiammineplatinum (NcS 119875): Therapeutic index in an animal model. Cancer 1977, 39: 1357-1361. DOI: https://doi.org/10.1002/1097-0142(197704)39:4<1357::AID-CNCR2820390402>3.0.CO;2-C
Hayes DM, Cvitkovic E, Golbery RB, Scheiner E, Helson L, Krakoff I: High dose cis-platinum diammine dichloride. Cancer 1977 39: 1372-1381. DOI: https://doi.org/10.1002/1097-0142(197704)39:4<1372::AID-CNCR2820390404>3.0.CO;2-J
Fleiss JL: Statistical methods for rates and proportions. New York, Wiley 1974.
MaxwellAE: Analisis estadistico de dados qualitativos. Mexico, Uthea, 1966.
Kimball AW: Short cut formulas for the exact partition of chi-square in contingency tables. Biometrics 1954, 10: 452-458. DOI: https://doi.org/10.2307/3001617
Vogl SE, Zaravinos T, Kaplan BH: Toxicity of cis-diamminedichloraplatinum II given in a two-hour outpatient regimen of diureses and hydration. Cancer 1980, 45: 11-15. DOI: https://doi.org/10.1002/1097-0142(19800101)45:1<11::AID-CNCR2820450104>3.0.CO;2-E
Prestayko AW, D'Aust JC. Issel BF, Crooke ST: Cisplatin (cis-diamminedichloroplatinum II). Cancer Treat Rev 1979, 6:17-39. DOI: https://doi.org/10.1016/S0305-7372(79)80057-2
Comis RL: Cisplatin nephrotoxicity: the effect of dose, schedule and hydration scheme, in Prestayko AW, Crooke ST, Carter SK (eds): Cisplatin: current status and new developments. New York, Academic Press, 1980, 485:493. DOI: https://doi.org/10.1016/B978-0-12-565050-2.50040-1
Weiner IVTsJ, Jacobs C: Mechanism of cisplatin nephrotoxicity. Federation Proc, 1983, 42: 2974-2978.
Doboyan DC, Levi J, Jacobs C. Kosek J, Weiner MN: Mechanism of cisplatinum nephrotoxicity: II. Morphologic observation. J. Pharmacol Exp Ther 1980, 213: 551-556.
Hardaker Jr. WT Stone RA, McCok R: Platinum nephrotoxicity. Cancer 1974, 34: 1030-1032. DOI: https://doi.org/10.1002/1097-0142(197410)34:4<1030::AID-CNCR2820340411>3.0.CO;2-C
Ward JM, Grabin ME, Leroy AF, Youg DM: Modification of the renal toxicity of cis-dichlorodiammineplatinum (II) with furosemide in male F 344 rats. Cancer treat Rep 1977, 6: 375-379.
Stark JJ. Howell SB: Nephrotoxicity of cis-platinum (II) dichlorodiammine. Clin Pharrnacol Ther 1978, 23:461-466. DOI: https://doi.org/10.1002/cpt1978234461
Madias NE Harrigton JT: Platinum nephrotoxicity. Am. J. Med 1978, 65: 307-314. DOI: https://doi.org/10.1016/0002-9343(78)90825-2
Von Hoff DO Schilsky R, Reichert CM, Reddick RL, Rosencweig M Youg RC et alI: Toxic effects of cis-dichlorodiammineplatinum (II) in man. Cancer Treat Rep 1979, 63: 1527-1531.
Krakoff 1H: Nephrotox icity of cis-dichlorodiammineplatinum (II) Cancer Treat Rep 1979, 63: 1523-1525.
Dentino M, Luft FC, Moo MY, Williams SD, Einhorn LH: Long term effect of cis-diamminedichlorídeplatinum (CDDP) renal function and structure in man. Cancer, 1978 41: 1274: 1281. DOI: https://doi.org/10.1002/1097-0142(197804)41:4<1274::AID-CNCR2820410410>3.0.CO;2-F
Blachley JD, Hill JB: Renal and electrolyte disturbance associated with cisplatin. Ann Inter Med 1981, 95: 628-632. DOI: https://doi.org/10.7326/0003-4819-95-5-628
Frick GA, Bailentine R. Dríever CW, KramerG Renal excetion kinetics of high - dose cis-dichlorodiammineplatinum (II) administered with hydration and rosnnitol diuresis. Cancer Treat Rep 1979, 63: 13-16.
Jones BR, Bhalla RB, Mladek J, Kaley RN, Gralla RJ, Alcock NW, et aI: Comparison of methods of evaluating nephrotoxicity of cis-platinum. Clin Pharmacol Ther 1980, 27: 557-562. DOI: https://doi.org/10.1038/clpt.1980.79
SaIem PA, Jabboury KW, Khalil MF: Severe nephrotoxicity: a probable complication of cis-dichlorodiammineplatinum (II) and cephalothin-gentamicin therapy Oncology 1982, 39: 31-32. DOI: https://doi.org/10.1159/000225600
Gonzales-Vitale JC, Hayes DM, Cvitkovic E, Sternberg SS: Acute renal failure after cis-dichlorodiammineplatinum (II) and gentamicin-cephalothin therapies. Cancer Treat Rep 1978, 62: 693-698.
Porter GA, Bennet WM. Nephrotoxic acute renal failure dueto common drugs. Am. J. Physiol 1981, 241: 1-8. DOI: https://doi.org/10.1152/ajprenal.1981.241.1.F1
Van Barneveld PWV, Sleifer DT, Van Der Mark TW, Mulder NH, Donker AJM, Meijer S, et aI: Influence of platinuminduced renal toxicity on Bleomycin induced pulmonar toxicity in patients with disseminated testicular carcinoma Oncology 1984, 41:4-7. DOI: https://doi.org/10.1159/000225781
Bennet WN, Pastore L, Houghton DC. Fatal pulmonar Blemycin toxicity in cisplatin-induced acute renal failure. Cancer Treat Rep 1980, 64: 921-924.